ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: SA-PO1096

Impact of Hyperglycemia on Renal Prognosis in Lean Individuals

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Author

  • Araki, Makoto, Sapporo Tokushukai Hospital, Sapporo, Japan
Background

Obesity not only affects blood glucose but also influences haemodynamics and adipocytokines, making it unclear to what extent hyperglycemia alone contributes to organ damage. Therefore, our aim was to investigate the specific impact of hyperglycemia on renal prognosis in lean individuals with elevated blood glucose levels.

Methods

In this single-center study from 2012 to 2022, we analyzed body mass index (BMI), estimated glomerular filtration rate (eGFR), and hemoglobin A1c (HbA1C) data. Individuals with a BMI <18.5 at any time were selected, excluding those under 18 years old, on dialysis, or with one year of data. Participants with HbA1C >6.5% were assigned to the hyperglycemic group (HBG), while the rest formed the control group (CG). Propensity score matching adjusted for background factors, and both groups underwent time-to-event analysis for a 40% eGFR decline. A 12-month landmark analysis minimized guarantee time bias.

Results

Among individuals with recorded BMI, 14.2% experienced a BMI below 18.5 during the study. Out of the initial 3149 individuals, 516 were classified as HBG, having a significantly higher average age than CG (74.3 vs. 63.7 years). Among those who did not reach a renal function endpoint within one year of enrollment, we selected a final sample of 484 patients in each group after adjusting for background factors including gender, age, first-year eGFR, duration of observation, and minimum BMI. The selected participants had a mean age of 74.9 years, mean duration of observation of 1755.4 days, and mean minimum BMI of 16.5. Survival time analysis showed that HBG reached the endpoint significantly more often than CG (Hazard ratio: 1.56 (95%CI 1.20-2.03), P < 0.001).

Conclusion

Lean individuals with hyperglycemia, who were more likely to be elderly, exhibited a significantly higher prevalence of impaired renal function compared to background-matched controls.